From November 22, the UK government announced that India’s Covaxin would be added to its list of authorized Covid-19 vaccines for overseas travelers, removing the need for people injected with the Bharat Biotech-produced vaccine to self-isolate after arriving in England. The decision comes in response to the World Health Organization’s (WHO) Emergency Use Listing for Covaxin, India’s second-most frequently used formulation. Last month, Covishield, an Oxford-AstraZeneca Covid-19 vaccine made in India, was added to the UK’s authorized list. There’s more good news for Indian visitors to the United Kingdom.
From November 22nd, travelers completely vaccinated with a COVID-19 vaccine recognized by the WHO for Emergency Use Listing, including Covaxin, will not be required to self-isolate, allowing them to join individuals fully vaccinated with Covishield, says the WHO. On Monday, the British High Commissioner to India, Alex Ellis, remarked on Twitter. On November 22, at 4 a.m., the adjustments will take effect. Apart from Covaxin, the UK government will recognize Sinovac and Sinopharm, both on the WHO Emergency Use List, as authorized vaccines for inbound travel, benefiting fully vaccinated persons from the United Arab Emirates and Malaysia.
These travelers will not be required to undergo a pre-departure test, a day-8 test, or self-isolate upon arrival because they are completely vaccinated. Today’s decisions signal the next phase in our resumption of international travel as they continue to recover from the epidemic and increase our recognition of overseas vaccinations, stated UK Transport, Secretary Grant Shapps. The red list and quarantine system continue to be critical in securing our borders, and as they have stated, they will not hesitate to take action by adding nations to the red list if required, “the UK Health Secretary stated.
The UK government has also made it easier for all under-18s visiting England to travel. They will now be treated as fully vaccinated at the border and will not be subject to self-isolation, day-8 testing, or pre-departure testing. If they test positive, they will only need to do one post-arrival test and one confirmatory free PCR test.